QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or Other Jurisdiction of Incorporation or Organization) |
(I.R.S. Employer Identification No.) | |
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | ||||
Non-accelerated filer |
☐ | Smaller reporting company | ||||
Emerging growth company |
Page |
||||
3 | ||||
3 | ||||
4 | ||||
5 | ||||
6 | ||||
7 | ||||
25 | ||||
34 | ||||
35 | ||||
36 | ||||
36 | ||||
36 | ||||
36 | ||||
36 | ||||
36 | ||||
36 | ||||
March 31, 2022 (Unaudited) |
December 31, 2021 |
|||||||
Assets |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | $ | ||||||
Commissions receivable, net |
||||||||
Prepaid expenses |
||||||||
Marketable debt securities, available-for-sale |
||||||||
Advances and loans, net |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total current assets |
||||||||
Property and equipment, net |
||||||||
Operating lease right-of-use |
||||||||
Marketable debt securities, available-for-sale |
||||||||
Assets held in rabbi trust |
||||||||
Deferred tax assets, net |
||||||||
Goodwill and other intangible assets, net |
||||||||
Advances and loans, net |
||||||||
Other assets |
||||||||
|
|
|
|
|||||
Total assets |
$ | $ | ||||||
|
|
|
|
|||||
Liabilities and stockholders’ equity |
||||||||
Current liabilities: |
||||||||
Accounts payable and other liabilities |
$ | $ | ||||||
Deferred compensation and commissions |
||||||||
Dividends payable |
||||||||
Income tax payable |
||||||||
Operating lease liabilities |
||||||||
Accrued bonuses and other employee related expenses |
||||||||
|
|
|
|
|||||
Total current liabilities |
||||||||
Deferred compensation and commissions |
||||||||
Operating lease liabilities |
||||||||
Other liabilities |
||||||||
|
|
|
|
|||||
Total liabilities |
||||||||
|
|
|
|
|||||
Commitments and contingencies |
||||||||
Stockholders’ equity: |
||||||||
Preferred stock, $ |
||||||||
Authorized shares – |
||||||||
Common stock, $ |
||||||||
Authorized shares – |
||||||||
Additional paid-in capital |
||||||||
Retained earnings |
||||||||
Accumulated other comprehensive income (loss) |
( |
) | ||||||
|
|
|
|
|||||
Total stockholders’ equity |
||||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ | $ | ||||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Revenues: |
||||||||
Real estate brokerage commissions |
$ | $ | ||||||
Financing fees |
||||||||
Other revenues |
||||||||
|
|
|
|
|||||
Total revenues |
||||||||
|
|
|
|
|||||
Operating expenses: |
||||||||
Cost of services |
||||||||
Selling, general and administrative |
||||||||
Depreciation and amortization |
||||||||
|
|
|
|
|||||
Total operating expenses |
||||||||
|
|
|
|
|||||
Operating income |
||||||||
Other income, net |
||||||||
Interest expense |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Income before provision for income taxes |
||||||||
Provision for income taxes |
||||||||
|
|
|
|
|||||
Net income |
$ | $ | ||||||
Other comprehensive (loss) income: |
||||||||
Marketable debt securities, available-for-sale: |
||||||||
Change in net unrealized gains/losses |
( |
) | ( |
) | ||||
Less: reclassification adjustment for net gains included in other income, net |
( |
) | ||||||
|
|
|
|
|||||
Net change, net of tax of $ |
( |
) | ( |
) | ||||
Foreign currency translation gain (loss), net of tax of $ |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total other comprehensive (loss) income |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Comprehensive income |
$ | $ | ||||||
|
|
|
|
|||||
Earnings per share: |
||||||||
Basic |
$ | $ | ||||||
Diluted |
$ | $ | ||||||
Weighted average common shares outstanding: |
||||||||
Basic |
||||||||
Diluted |
Three Months Ended March 31, 2022 | ||||||||||||||||||||||||||||||||||||
Preferred Stock | Common Stock | Additional Paid-In Capital |
Stock Notes Receivable From Employees |
Retained Earnings |
Accumulated Other Comprehensive Income (Loss) |
Total | ||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||
Balance at December 31, 2021 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net and comprehensive income (loss) |
— | — | ( |
) | ||||||||||||||||||||||||||||||||
Stock-based award activity |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
||||||||||||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
Dividends on common stock |
— | — | — | — | — | — | ( |
) | — | ( |
) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of March 31, 2022 |
$ | $ | $ | $ | $ | $ | ( |
) | $ | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2021 | ||||||||||||||||||||||||||||||||||||
Preferred Stock | Common Stock | Additional Paid-In Capital |
Stock Notes Receivable From Employees |
Retained Earnings |
Accumulated Other Comprehensive Income |
Total | ||||||||||||||||||||||||||||||
Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||||||
Balance at December 31, 2020 |
$ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||||||
Net and comprehensive income |
— | — | ( |
) | ||||||||||||||||||||||||||||||||
Stock-based award activity |
||||||||||||||||||||||||||||||||||||
Stock-based compensation |
||||||||||||||||||||||||||||||||||||
Issuance of common stock for vesting of restricted stock units |
||||||||||||||||||||||||||||||||||||
Shares withheld related to net share settlement of stock-based awards |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance as of March 31, 2021 |
$ | $ | $ | $ | $ | $ | |
$ | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Cash flows from operating activities |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Depreciation and amortization |
||||||||
Noncash lease expense |
||||||||
Credit loss recovery |
( |
) | ( |
) | ||||
Stock-based compensation |
||||||||
Deferred taxes, net |
||||||||
Unrealized foreign exchange (gains) losses |
( |
) | ( |
) | ||||
Net realized gains on marketable debt securities, available-for-sale |
( |
) | ( |
) | ||||
Other non-cash items |
( |
) | ||||||
Changes in operating assets and liabilities: |
||||||||
Commissions receivable |
||||||||
Prepaid expenses |
||||||||
Advances and loans |
( |
) | ( |
) | ||||
Other assets |
( |
) | ( |
) | ||||
Accounts payable and other liabilities |
||||||||
Income tax receivable/payable |
||||||||
Accrued bonuses and other employee related expenses |
( |
) | ( |
) | ||||
Deferred compensation and commissions |
( |
) | ( |
) | ||||
Operating lease liabilities |
( |
) | ( |
) | ||||
Other liabilities |
( |
) | ( |
) | ||||
Net cash flows used in operating activities |
( |
) | ( |
) | ||||
Cash flows from investing activities |
||||||||
Acquisition of businesses, net of cash received |
( |
) | ||||||
Purchases of marketable debt securities, available-for-sale |
( |
) | ( |
) | ||||
Proceeds from sales and maturities of marketable debt securities, available-for-sale |
||||||||
Issuances of employee notes receivable |
( |
) | ( |
) | ||||
Payments received on employee notes receivable |
||||||||
Purchase of property and equipment |
( |
) | ( |
) | ||||
Net cash flows provided by investing activities |
||||||||
Cash flows from financing activities |
||||||||
Taxes paid related to net share settlement of stock-based awards |
( |
) | ( |
) | ||||
Principal payments on stock appreciation rights liability |
( |
) | ( |
) | ||||
Principal payments on contingent and deferred consideration |
( |
) | ( |
) | ||||
Net cash flows used in financing activities |
( |
) | ( |
) | ||||
Effect of currency exchange rate changes on cash and cash equivalents |
||||||||
Net (decrease) in cash and cash equivalents |
( |
) | ( |
) | ||||
Cash and cash equivalents at beginning of period |
||||||||
Cash and cash equivalents at end of period |
$ | $ | ||||||
Supplemental disclosures of cash flow information |
||||||||
Interest paid during the period |
$ | $ | ||||||
Income taxes paid, net |
$ | $ | ||||||
1. |
Description of Business, Basis of Presentation and Recent Accounting Pronouncements |
2. |
Property and Equipment, Net |
March 31, 2022 |
December 31, 2021 |
|||||||
Computer software and hardware equipment |
$ | $ | ||||||
Furniture, fixtures and equipment |
||||||||
Less: accumulated depreciation and amortization |
( |
) | ( |
) | ||||
$ | $ | |||||||
3. |
Operating Leases |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Operating lease cost: |
||||||||
Lease cost (1) |
$ | $ | ||||||
Variable lease cost (2) |
||||||||
Sublease income |
( |
) | ( |
) | ||||
$ | $ | |||||||
(1) |
Includes short-term lease cost and ROU asset amortization. |
(2) |
Primarily relates to common area maintenance, property taxes, insurance, utilities and parking. |
March 31, 2022 | ||||
Remainder of 2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
Total future minimum lease payments |
||||
Less imputed interest |
( |
) | ||
Present value of operating lease liabilities |
$ | |||
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Operating cash flow information: |
||||||||
Cash paid for amounts included in the measurement of operating lease liabilities |
$ | $ | ||||||
Noncash activity: |
||||||||
ROU assets obtained in exchange for operating lease liabilities |
$ | $ | ||||||
Tenant improvements owned by lessor related to ROU assets (1) |
$ | $ |
(1) |
Reclassification from other assets current. |
March 31, 2022 | December 31, 2021 | |||||||
Weighted average remaining operating lease term |
||||||||
Weighted average discount rate |
% | % |
4. |
Investments in Marketable Debt Securities, Available for Sale |
March 31, 2022 | ||||||||||||||||||||
Amortized Cost |
Allowance for Credit Losses |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
||||||||||||||||
Short-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
Asset-backed securities (“ABS”) and other |
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ |
|
|
$ | $ | $ | ( |
) | $ | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Long-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||
U.S. government sponsored entities |
( |
) | ||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
Asset-backed securities (“ABS”) and other |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
December 31, 2021 | ||||||||||||||||||||
Amortized Cost |
Allowance for Credit Losses |
Gross Unrealized Gains |
Gross Unrealized Losses |
Fair Value |
||||||||||||||||
Short-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Long-term investments: |
||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | ( |
) | $ | |||||||||||||
U.S. government sponsored entities |
( |
) | ||||||||||||||||||
Corporate debt |
( |
) | ||||||||||||||||||
ABS and other |
( |
) | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
$ | $ | $ | $ | ( |
) | $ | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
March 31, 2022 | ||||||||||||||||||||||||
Less than 12 months | 12 months or greater | Total | ||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
U.S. treasuries |
$ | $ | ( |
) | $ | $ | ( |
) | ||||||||||||||||
U.S. government sponsored entities |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Corporate debt |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
ABS and other |
( |
) | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2021 | ||||||||||||||||||||||||
Less than 12 months | 12 months or greater | Total | ||||||||||||||||||||||
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
Fair Value |
Gross Unrealized Losses |
|||||||||||||||||||
U.S. treasuries |
$ | $ | ( |
) | $ | $ | $ | $ | ( |
) | ||||||||||||||
U.S. government sponsored entities |
( |
) | ( |
) | ||||||||||||||||||||
Corporate debt |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
ABS and other |
( |
) | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | $ | ( |
) | $ | $ | ( |
) | $ | $ | ( |
) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Gross realized gains (1) |
$ | $ | ||||||
|
|
|
|
|||||
Gross realized losses (1) |
$ | $ | ||||||
|
|
|
|
(1) |
Recorded in other income, net in the condensed consolidated statements of net and comprehensive income. The cost basis of securities sold were determined based on the specific identification method. |
March 31, 2022 | December 31, 2021 | |||||||||||||||
Amortized Cost |
Fair Value | Amortized Cost |
Fair Value | |||||||||||||
Due in one year or less |
$ | $ | $ | $ | ||||||||||||
Due after one year through five years |
||||||||||||||||
Due after five years through ten years |
||||||||||||||||
Due after ten years |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Weighted average contractual maturity |
5. |
Acquisitions, Goodwill and Other Intangible Assets |
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||||
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
Gross Carrying Amount |
Accumulated Amortization |
Net Book Value |
|||||||||||||||||||
Goodwill and intangible assets: |
||||||||||||||||||||||||
Goodwill |
$ | $ | — | $ | $ | $ | — | $ | ||||||||||||||||
Intangible assets (1) |
( |
) | ( |
) | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$ | $ | ( |
) | $ | $ | $ | ( |
) | $ | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Total weighted average amortization period was |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Beginning balance |
$ | $ | ||||||
Additions from acquisitions (1) |
||||||||
Impairment losses |
||||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
(1) |
The 2021 addition represents a measurement period adjustment for an acquisition made in 2020. |
March 31, 2022 | ||||
Remainder of 2022 |
$ | |||
2023 |
||||
2024 |
||||
2025 |
||||
2026 |
||||
Thereafter |
||||
|
|
|||
$ | ||||
|
|
6. |
Selected Balance Sheet Data |
Current | Non-Current |
|||||||||||||||
March 31, 2022 |
December 31, 2021 |
March 31, 2022 |
December 31, 2021 |
|||||||||||||
Mortgage servicing rights (“MSRs”), net of amortization |
$ | $ | $ | $ | ||||||||||||
Security deposits |
||||||||||||||||
Employee notes receivable (1) |
||||||||||||||||
Securities, held-to-maturity (2) |
||||||||||||||||
Customer trust accounts and other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
(1) |
Reduction of accrued bonuses and other employee related expenses in settlement of employee notes receivable were $ |
(2) |
Securities, held-to-maturity, |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Beginning balance |
$ | $ | ||||||
Additions |
||||||||
Amortization |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
Current | Non-Current |
|||||||||||||||
March 31, 2022 |
December 31, 2021 |
March 31, 2022 |
December 31, 2021 |
|||||||||||||
Stock appreciation rights (“SARs”) liability (1) |
$ | $ | $ | $ | ||||||||||||
Commissions payable to investment sales and financing professionals |
||||||||||||||||
Deferred compensation liability (1) |
||||||||||||||||
Other |
||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | $ | $ | $ | |||||||||||||
|
|
|
|
|
|
|
|
(1) |
The SARs and deferred compensation liability become subject to payout as a result of a participant no longer being considered a service provider. As a result of the retirement of certain participants, estimated amounts to be paid to the participants within the next twelve months have been classified as current. |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Increase (Decrease) in the carrying value of the assets held in the rabbi trust (1) |
$ | ( |
) | $ | ||||
|
|
|
|
|||||
Increase (Decrease) in the net carrying value of the deferred compensation obligation (2) |
$ | ( |
) | $ | ||||
|
|
|
|
(1) |
Recorded in other income, net in the condensed consolidated statements of net and comprehensive income. |
(2) |
Recorded in selling, general and administrative expense in the condensed consolidated statements of net and comprehensive income. |
Non-Current |
||||||||
March 31, 2022 |
December 31, 2021 |
|||||||
Deferred consideration (1) |
$ | $ | ||||||
Contingent consideration (1) |
||||||||
Dividends Payable |
||||||||
Other |
||||||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
(1) |
Includes a measurement period adjustment in 2021 and a settlement of deferred consideration made during the three months ended March 31, 2022 and 2021, which represents a noncash investing activity. See Note 5 – “Acquisitions, Goodwill and Other Intangible Assets” for additional information. |
7 . |
Related-Party Transactions |
8. |
Fair Value Measurements |
• | Level 1: |
• | Level 2: |
• | Level 3: |
March 31, 2022 | December 31, 2021 | |||||||||||||||||||||||||||||||
Fair Value | Level 1 | Level 2 | Level 3 | Fair Value | Level 1 | Level 2 | Level 3 | |||||||||||||||||||||||||
Assets: |
||||||||||||||||||||||||||||||||
Assets held in rabbi trust |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Cash equivalents (1) |
||||||||||||||||||||||||||||||||
Commercial paper |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Money market funds |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Marketable debt securities, available-for-sale: |
||||||||||||||||||||||||||||||||
Short-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||||||||||||||
Corporate debt |
||||||||||||||||||||||||||||||||
ABS and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Long-term investments: |
||||||||||||||||||||||||||||||||
U.S. treasuries |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
U.S. government sponsored entities |
||||||||||||||||||||||||||||||||
Corporate debt |
||||||||||||||||||||||||||||||||
ABS and other |
||||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
$ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Liabilities: |
||||||||||||||||||||||||||||||||
Contingent consideration (2) |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Deferred consideration (2) |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Deferred compensation liability |
$ | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Included in cash and cash equivalents on the accompanying condensed consolidated balance sheets. |
(2) |
$ |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Beginning balance |
$ | $ | ||||||
Contingent consideration in connection with acquisitions (1) |
( |
) | ||||||
Change in fair value of contingent consideration |
( |
) | ||||||
Payments of contingent consideration |
||||||||
|
|
|
|
|||||
Ending balance |
$ | $ | ||||||
|
|
|
|
(1) |
Contingent consideration in connection with acquisitions represents a noncash investing activity. Three months ended March 31, 2021 relates to a measurement period adjustment. See Note 5 – “Acquisitions, Goodwill and Other Intangible Assets” for additional information. |
Fair Value at March 31, 2022 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
Contingent consideration |
$ | Discounted cash flow | Expected life of cash flows | y ears) |
||||||||
Discount rate | ||||||||||||
Probability of achievement | ||||||||||||
Fair Value at December 31, 2021 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
Contingent consideration |
$ | Discounted cash flow | Expected life of cash flows | |||||||||
Discount rate | ||||||||||||
Probability of achievement |
(1) |
Unobservable inputs were weighted by the relative fair value of the instruments. |
Fair Value at March 31, 2022 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
MSRs |
$ | Discounted cash flow | Constant prepayment rates | |||||||||
Constant default rate | ||||||||||||
Loss severity | ||||||||||||
Discount rate | ||||||||||||
Fair Value at December 31, 2021 |
Valuation Technique |
Unobservable inputs |
Range (Weighted Average) (1) |
|||||||||
MSRs |
$ | Discounted cash flow | Constant prepayment rates | |||||||||
Constant default rate | ||||||||||||
Loss severity | ||||||||||||
Discount rate |
(1) |
Weighted average is based on the |
9. |
Stockholders’ Equity |
10. |
Stock-Based Compensation Plans |
Shares | Weighted- Average Grant Date Fair Value Per Share |
|||||||
Nonvested shares at December 31, 2021 (1) |
$ | |||||||
Granted |
$ | |||||||
Vested (2) |
( |
) | $ | |||||
Forfeited/canceled |
( |
) | $ | |||||
|
|
|||||||
Nonvested shares at March 31, 2022 (1) |
$ | |||||||
|
|
|||||||
Unrecognized stock-based compensation expense as of March 31, 2022 |
$ | |||||||
|
|
|||||||
Unrecognized compensation expense is expected to be recognized over a weighted-average period (years) of approximately |
||||||||
|
|
|||||||
Weighted average remaining vesting period (years) as of March 31, 2022 |
||||||||
|
|
(1) |
Nonvested RSUs will be settled through the issuance of new shares of common stock. |
(2) |
Includes vested shares delivered subsequent to March 31, 2022. |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
ESPP |
$ | $ | ||||||
RSUs and RSAs |
||||||||
|
|
|
|
|||||
$ | $ | |||||||
|
|
|
|
11. |
Income Taxes |
Three Months Ended March 31, | ||||||||||||||||
2022 | 2021 | |||||||||||||||
Amount | Rate | Amount | Rate | |||||||||||||
Income tax expense at the federal statutory rate |
$ | % | $ | % | ||||||||||||
State income tax expense, net of federal benefit |
% | % | ||||||||||||||
(Windfall) shortfall tax benefits, net related to stock-based compensation |
( |
) | ( |
)% | ( |
) | ( |
)% | ||||||||
Change in valuation allowance |
( |
) | ( |
)% | % | |||||||||||
Permanent and other items (1) |
% | % | ||||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | % | $ | % | |||||||||||||
|
|
|
|
|
|
|
|
(1) |
Permanent items relate principally to compensation charges, qualified transportation fringe benefits and meals and entertainment. |
12. |
Earnings per Share |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Numerator (Basic and Diluted): |
||||||||
Net income |
$ | $ | ||||||
Change in value for stock settled consideration |
( |
) | ||||||
|
|
|
|
|||||
Adjusted net income |
$ | $ | ||||||
|
|
|
|
|||||
Denominator: |
||||||||
Basic |
||||||||
Weighted average common shares issued and outstanding |
||||||||
Deduct: Unvested RSAs (1) |
( |
) | ( |
) | ||||
Add: Fully vested DSUs (2) |
||||||||
|
|
|
|
|||||
Weighted average common shares outstanding |
||||||||
|
|
|
|
|||||
Basic earnings per common share |
$ | $ | ||||||
|
|
|
|
|||||
Diluted |
||||||||
Weighted average common shares outstanding from above |
||||||||
Add: Dilutive effect of RSUs, RSAs & ESPP |
||||||||
Add: Contingently issuable shares (3) |
||||||||
|
|
|
|
|||||
Weighted average common shares outstanding |
||||||||
|
|
|
|
|||||
Diluted earnings per common share |
$ | $ | ||||||
|
|
|
|
|||||
Antidilutive shares excluded from diluted earnings per common share (4) |
||||||||
|
|
|
|
(1) |
RSAs were issued and outstanding to the non-employee directors and have a |
(2) |
Shares are included in weighted average common shares outstanding as the shares are fully vested but have not yet been delivered. See Note 10 – “Stock-Based Compensation Plans” for additional information. |
(3) |
Relates to contingently issuable stock settled consideration. |
(4) |
Primarily pertaining to RSU grants to the Company’s employees and independent contractors. |
13. |
Commitments and Contingencies |
14. |
Subsequent Events |
• | Properties priced less than $1 million; |
• | Private client market: |
• | Middle market: |
• | Larger transaction market: |
Three Months Ended March 31, | ||||||||||||||||||||||||||||||||||||
2022 | 2021 | Change | ||||||||||||||||||||||||||||||||||
Real Estate Brokerage |
Number | Volume | Revenues | Number | Volume | Revenues | Number | Volume | Revenues | |||||||||||||||||||||||||||
(in millions) | (in thousands) | (in millions) | (in thousands) | (in millions) | (in thousands) | |||||||||||||||||||||||||||||||
<$1 million |
206 | $ | 128 | $ | 5,787 | 227 | $ | 149 | $ | 6,138 | (21 | ) | $ | (21 | ) | $ | (351 | ) | ||||||||||||||||||
Private Client Market ($1 - <$10 million) |
1,606 | 5,696 | 161,031 | 1,200 | 3,668 | 105,423 | 406 | 2,028 | 55,608 | |||||||||||||||||||||||||||
Middle Market ($10 - <$20 million) |
184 | 2,503 | 46,760 | 78 | 1,067 | 20,601 | 106 | 1,436 | 26,159 | |||||||||||||||||||||||||||
Larger Transaction Market (≥$20 million) |
141 | 8,878 | 73,331 | 83 | 3,980 | 30,634 | 58 | 4,898 | 42,697 | |||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
2,137 | $ | 17,205 | $ | 286,909 | 1,588 | $ | 8,864 | $ | 162,796 | 549 | $ | 8,341 | $ | 124,113 | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
||||||||
Real Estate Brokerage |
2022 | 2021 | ||||||
Average Number of Investment Sales Professionals |
1,856 | 1,959 | ||||||
Average Number of Transactions per Investment Sales Professional |
1.15 | 0.81 | ||||||
Average Commission per Transaction |
$ | 134,258 | $ | 102,517 | ||||
Average Commission Rate |
1.67 | % | 1.84 | % | ||||
Average Transaction Size (in thousands) |
$ | 8,051 | $ | 5,582 | ||||
Total Number of Transactions |
2,137 | 1,588 | ||||||
Total Sales Volume (in millions) |
$ | 17,205 | $ | 8,864 | ||||
Three Months Ended March 31, |
||||||||
Financing (1) |
2022 | 2021 | ||||||
Average Number of Financing Professionals |
84 | 86 | ||||||
Average Number of Transactions per Financing Professional |
6.19 | 5.74 | ||||||
Average Fee per Transaction |
$ | 43,144 | $ | 30,464 | ||||
Average Fee Rate |
0.84 | % | 0.93 | % | ||||
Average Transaction Size (in thousands) |
$ | 5,115 | $ | 3,263 | ||||
Total Number of Transactions |
520 | 494 | ||||||
Total Financing Volume (in millions) |
$ | 2,660 | $ | 1,612 |
(1) |
Operating metrics exclude certain financing fees not directly associated to transactions. |
Three Months Ended March 31, 2022 |
Percentage of Revenue |
Three Months Ended March 31, 2021 |
Percentage of Revenue |
Change | ||||||||||||||||||||
Dollar | Percentage | |||||||||||||||||||||||
Revenues: |
||||||||||||||||||||||||
Real estate brokerage commissions |
$ | 286,909 | 89.8 | % | $ | 162,796 | 88.5 | % | $ | 124,113 | 76.2 | % | ||||||||||||
Financing fees |
26,453 | 8.3 | 17,843 | 9.7 | 8,610 | 48.3 | % | |||||||||||||||||
Other revenues |
6,102 | 1.9 | 3,338 | 1.8 | 2,764 | 82.8 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total revenues |
319,464 | 100.0 | 183,977 | 100.0 | 135,487 | 73.6 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of services |
196,768 | 61.6 | 109,103 | 59.3 | 87,665 | 80.4 | % | |||||||||||||||||
Selling, general and administrative |
74,535 | 23.3 | 51,677 | 28.1 | 22,858 | 44.2 | % | |||||||||||||||||
Depreciation and amortization |
3,911 | 1.2 | 2,997 | 1.6 | 914 | 30.5 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Total operating expenses |
275,214 | 86.1 | 163,777 | 89.0 | 111,437 | 68.0 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Operating income |
44,250 | 13.8 | 20,200 | 11.0 | 24,050 | 119.1 | % | |||||||||||||||||
Other income, net |
450 | 0.1 | 1,044 | 0.6 | (594 | ) | (56.9 | )% | ||||||||||||||||
Interest expense |
(160 | ) | 0.0 | (146 | ) | (0.1 | ) | (14 | ) | 9.6 | % | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Income before provision for income taxes |
44,540 | 13.9 | 21,098 | 11.5 | 23,442 | 111.1 | % | |||||||||||||||||
Provision for income taxes |
11,757 | 3.7 | 6,086 | 3.3 | 5,671 | 93.2 | % | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Net income |
$ | 32,783 | 10.3 | % | $ | 15,012 | 8.2 | % | $ | 17,771 | 118.4 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Adjusted EBITDA (1) |
$ | 51,852 | 16.2 | % | $ | 25,695 | 14.0 | % | $ | 26,157 | 101.8 | % | ||||||||||||
|
|
|
|
|
|
|
|
|
|
(1) |
Adjusted EBITDA is not a measurement of our financial performance under U.S. generally accepted accounting principles (“U.S. GAAP”) and should not be considered as an alternative to net income, operating income or any other measures derived in accordance with U.S. GAAP. For a definition of Adjusted EBITDA and a reconciliation of Adjusted EBITDA to net income, see “Non-GAAP Financial Measure.” |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Net income |
$ | 32,783 | $ | 15,012 | ||||
Adjustments: |
||||||||
Interest income and other (1) |
(615 | ) | (531 | ) | ||||
Interest expense |
160 | 146 | ||||||
Provision for income taxes |
11,757 | 6,086 | ||||||
Depreciation and amortization |
3,911 | 2,997 | ||||||
Stock-based compensation |
3,856 | 2,288 | ||||||
Non-cash MSR activity (2) |
— | (303 | ) | |||||
|
|
|
|
|||||
Adjusted EBITDA (3) |
$ | 51,852 | $ | 25,695 | ||||
|
|
|
|
(1) |
Other includes net realized gains (losses) on marketable debt securities available-for-sale. |
(2) |
Non-cash MSR activity includes the assumption of servicing obligations. |
(3) |
The increase in Adjusted EBITDA for the three months ended March 31, 2022 compared to the same period in 2021 is primarily due to a lower proportion of operating expenses compared to total revenues. |
Three Months Ended March 31, |
||||||||
2022 | 2021 | |||||||
Net cash flows from operating activities |
$ | (67,535 | ) | $ | (20,102) | |||
Net cash flows from investing activities |
6,983 | 3,141 | ||||||
Net cash flows from financing activities |
(5,943 | ) | (4,516 | ) | ||||
|
|
|
|
|||||
Effect of currency exchange rate changes on cash and cash equivalents |
50 | 33 | ||||||
|
|
|
|
|||||
Net increase (decrease) in cash and cash equivalents |
(66,445 | ) | (21,444 | ) | ||||
Cash and cash equivalents at beginning of period |
382,140 | 243,152 | ||||||
|
|
|
|
|||||
Cash and cash equivalents at end of period |
$ | 315,695 | $ | 221,708 | ||||
|
|
|
|
Change in Interest Rates |
Approximate Change in Fair Value of Investments Increase (Decrease) |
|||
2% Decrease |
$ | 4,585 | ||
1% Decrease |
$ | 2,574 | ||
1% Increase |
$ | (2,615) | ||
2% Increase |
$ | (5,229) |
Exhibit No. |
Description | |
31.1* | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
31.2* | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |
32.1** | Certifications of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) under the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |
101* | The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Net and Comprehensive Income, (iii) Condensed Consolidated Statements of Stockholders’ Equity, (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags. | |
104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
* |
Filed herewith. |
** |
Furnished, not filed. |
Marcus & Millichap, Inc | ||||||||
Date: | May 6, 2022 |
By: | /s/ Hessam Nadji | |||||
Hessam Nadji President and Chief Executive Officer (Principal Executive Officer) | ||||||||
Date: | May 6, 2022 |
By: | /s/ Steven F. DeGennaro | |||||
Steven F. DeGennaro Chief Financial Officer (Principal Financial Officer) |